179 related articles for article (PubMed ID: 22980431)
1. Misoprostol for the management of postpartum bleeding: a new approach.
Dabash R; Blum J; Raghavan S; Anger H; Winikoff B
Int J Gynaecol Obstet; 2012 Dec; 119(3):210-2. PubMed ID: 22980431
[TBL] [Abstract][Full Text] [Related]
2. A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt.
Anger HA; Dabash R; Hassanein N; Darwish E; Ramadan MC; Nawar M; Charles D; Breebaart M; Winikoff B
BMC Pregnancy Childbirth; 2020 May; 20(1):317. PubMed ID: 32448257
[TBL] [Abstract][Full Text] [Related]
3. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
[TBL] [Abstract][Full Text] [Related]
4. Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage - Do Costs Matter?
Chatterjee S; Sarkar A; Rao KD
PLoS One; 2016; 11(10):e0164718. PubMed ID: 27755601
[TBL] [Abstract][Full Text] [Related]
5. Misoprostol for prevention and treatment of postpartum hemorrhage: what do we know? What is next?
Raghavan S; Abbas D; Winikoff B
Int J Gynaecol Obstet; 2012 Oct; 119 Suppl 1():S35-8. PubMed ID: 22883912
[TBL] [Abstract][Full Text] [Related]
6. Prevention of postpartum hemorrhage with misoprostol.
International Federation Of Gynecology and Obstetrics
Int J Gynaecol Obstet; 2012 Dec; 119(3):213-4. PubMed ID: 23022109
[No Abstract] [Full Text] [Related]
7. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
Oladapo OT
Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139
[TBL] [Abstract][Full Text] [Related]
8. Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India.
Kodkany BS; Derman RJ; Goudar SS; Geller SE; Edlavitch SA; Naik VA; Patel A; Bellad MB; Patted SS
Int J Fertil Womens Med; 2004; 49(2):91-6. PubMed ID: 15188836
[TBL] [Abstract][Full Text] [Related]
9. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
[TBL] [Abstract][Full Text] [Related]
10. Rectally administrated misoprostol as an alternative to intravenous oxytocin infusion for preventing post-partum hemorrhage after cesarean delivery.
Chaudhuri P; Mandi S; Mazumdar A
J Obstet Gynaecol Res; 2014 Sep; 40(9):2023-30. PubMed ID: 25181622
[TBL] [Abstract][Full Text] [Related]
11. Misoprostol: preventing postpartum haemorrhage.
Walder J
Mod Midwife; 1997 Sep; 7(9):23-7. PubMed ID: 9370621
[TBL] [Abstract][Full Text] [Related]
12. Misoprostol for the prevention and treatment of postpartum hemorrhage.
Sheldon WR; Blum J; Durocher J; Winikoff B
Expert Opin Investig Drugs; 2012 Feb; 21(2):235-50. PubMed ID: 22233426
[TBL] [Abstract][Full Text] [Related]
13. Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention.
Prata N; Bell S; Quaiyum MA
BMC Pregnancy Childbirth; 2014 Feb; 14():78. PubMed ID: 24555848
[TBL] [Abstract][Full Text] [Related]
14. Treatment of postpartum hemorrhage with misoprostol.
International Federation Of Gynecology And Obstetrics
Int J Gynaecol Obstet; 2012 Dec; 119(3):215-6. PubMed ID: 23036964
[No Abstract] [Full Text] [Related]
15. Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda.
Lubinga SJ; Atukunda EC; Wasswa-Ssalongo G; Babigumira JB
PLoS One; 2015; 10(11):e0142550. PubMed ID: 26560140
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for scale-up of community-based misoprostol distribution programs.
Robinson N; Kapungu C; Carnahan L; Geller S
Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582
[TBL] [Abstract][Full Text] [Related]
17. Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage.
Haque N; Bilkis L; Haque N; Bari MS; Haque S
Mymensingh Med J; 2009 Jan; 18(1 Suppl):S40-44. PubMed ID: 19377430
[TBL] [Abstract][Full Text] [Related]
18. Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
Hashima-E-Nasreen ; Nahar S; Al Mamun M; Afsana K; Byass P
Glob Health Action; 2011; 4():. PubMed ID: 21845143
[TBL] [Abstract][Full Text] [Related]
19. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
Chaudhuri P; Biswas J; Mandal A
Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
[TBL] [Abstract][Full Text] [Related]
20. Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.
Zvandasara P; Chipato T; Mawere E; Rivelt K; McNally T
Cent Afr J Med; 2015; 61(9-12):76-83. PubMed ID: 29144067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
